ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2122

Coronary Calcium and Carotid Artery Stiffness as Predictors of Cardiovascular Events and Mortality in Patients with Rheumatoid Arthritis: A 10-year Prospective Follow-up Study

Cristina Corrales Selaya1, Nuria Vegas Revenga2, Jose Antonio Parra3, Virginia Portilla4, Ricardo Blanco5, Miguel A Gonzalez-Gay6, Ivan Ferraz Amaro7 and Alfonso Corrales4, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Hospital Galdakao- Usansolo, Galdakao, Spain, 3Hospital Universitario Marques de Valdecilla, Santander, Spain, 4Rheumatology Department, Immunopathology Group, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain, 5Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 6IDIVAL and School of Medicine, UC, Santander; Department of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid, Santander, Spain, 7Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain

Meeting: ACR Convergence 2023

Keywords: Cardiovascular, Mortality, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The risk of mortality is increased in patients with RA compared to the general population. Different non-invasive surrogate markers of atherosclerosis have been implemented to identify RA patients who are at high risk of cardiovascular (CV) disease.
In the present study, we aimed to establish the predictive capacity of the following surrogate markers: Coronary calcium (CAC) and carotid pulse wave velocity (PWV) to predict CV events and all-cause mortality in a cohort of RA patients prospectively followed.

Methods: We conducted a prospective longitudinal study that included 126 patients with RA. The patients were recruited in 2011 and followed-up for 10 years. All patients had undergone baseline CAC score, and carotid PWV by US. Multivariate Cox regression analysis was performed to identify the predictive ability of these surrogate markers for CV events and all-cause mortality.

Results: A total of 126 patients were included, 92 women (73%), with a mean age of 59±10 years. The main baseline characteristics, CV risk factors, disease activity data and treatments are detailed in Table 1, as well as the baseline parameters that showed statistically significant association with mortality and CV events. After a follow-up of 14,479 person-months, there were 15 deaths and 24 cardiovascular events in 18 patients. The main causes of mortality were infections (n=7, 46.7%) and neoplasms (n=5, 33.3%). In univariate analysis, CAC values above 400 Agatston units were associated with a statistically significant increased risk of overall mortality (HR 5.13 (1.03-25.41 95% CI), p=0.045) (Table 2). However, in multivariate analysis adjusted for classical CV risk factors, the results obtained were not statistically significant. Increasing CAC value as a continuous variable was significantly associated with an increased risk of cardiovascular event in both univariate (HR 1.002 (1.0008-1.003 95% CI), p=0.001) and multivariate (HR 1.002 (1.0004- 1.003), p=0.011) analyses. The increase in carotid arterial stiffness value measured by PWV was statistically significantly related to overall mortality in the univariate analysis. The same was observed when categorizing this variable, as values higher than 10 m/s in the univariate analysis were statistically associated with overall mortality. However, this relationship did not maintain in the multivariate analysis, nor could it be demonstrated for CV events.

Conclusion: CAC measurement in RA patients is predictive of CV events. In our cohort of 126 RA patients, increased PWV values did not correlate with overall mortality or CVD after 10 years of follow-up.

Supporting image 1

Table 1. Baseline characteristics of a cohort of 126 arthritis patients without previous cardiovascular events.

Supporting image 2

Table 2. Cox regression analysis hazard ratios for death of any cause and cardiovascular events of non-invasive surrogate markers of atherosclerosis.


Disclosures: C. Corrales Selaya: None; N. Vegas Revenga: None; J. Parra: None; V. Portilla: None; R. Blanco: AbbVie, 5, 6, Amgen, 6, AstraZeneca, 2, BMS, 6, Eli Lilly, 6, Galapagos, 2, 6, Janssen, 2, 6, MSD, 6, Novartis, 2, 6, Pfizer, 2, 6, Roche, 5, 6, Sanofi, 6; M. Gonzalez-Gay: AbbVie/Abbott, 5, 6, Amgen, 5, 6, Pfizer, 5, 6; I. Ferraz Amaro: AbbVie/Abbott, 5, 6, Amgen, 5, 6, Bristol-Myers Squibb(BMS), 6; A. Corrales: None.

To cite this abstract in AMA style:

Corrales Selaya C, Vegas Revenga N, Parra J, Portilla V, Blanco R, Gonzalez-Gay M, Ferraz Amaro I, Corrales A. Coronary Calcium and Carotid Artery Stiffness as Predictors of Cardiovascular Events and Mortality in Patients with Rheumatoid Arthritis: A 10-year Prospective Follow-up Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/coronary-calcium-and-carotid-artery-stiffness-as-predictors-of-cardiovascular-events-and-mortality-in-patients-with-rheumatoid-arthritis-a-10-year-prospective-follow-up-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/coronary-calcium-and-carotid-artery-stiffness-as-predictors-of-cardiovascular-events-and-mortality-in-patients-with-rheumatoid-arthritis-a-10-year-prospective-follow-up-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology